*See 5-10% upside in Indian mkt in near-term: Credit Suisse
*RBI may start accumulating reserves at Rs 58-60/$: Nomura
*Any further rate hike to push corporates over default cliff: India Ratings
*IMF throws $27-billion financial lifeline to Ukraine
*Euro, peripheral bond yields fall as speculation grows over ECB easing rates
*Unable to pay Rs 10,000 crore, Sahara counsel tells SC
*SC wants Gavaskar as interim BCCI President
*Sebi mulls pension fund for employees
*Sebi to carry investor campaigns via mobile, Internet in FY15
*India Cements falls 2% on SC proposals in IPL scam probe
*Jet, SpiceJet soar 5-7% , RBI extends ECB borrowing window
*State Bank of India up 4%, Goldman Sachs upgrades to buy
*Talwalkars at 14-month high, up 14% on stake sale noise
*Shriram City’s Rs 200-crore NCD to open on April 16
*Mining production cap at 20 MTPA in Goa acceptable: FIMI
*Demand to grow by at least 6% next fiscal: Tata Steel MD
*Suzlon needs leadership from outside promoter family: IiAS
*Colgate Palmolive declares third interim dividend
*Ruchi Soya expects sunflower oil imports to hit record high
*Titan to set up second lens unit, to add 60 more stores next year
*Shipping Ministry to seek VGF for two proposed major ports
*Star Alliance satisfied with AI preparations for membership
*Coal India sees production growing 6.7 per cent next fiscal
*Shriram City’s Rs 200-crore NCD to open on April 16
*Compat dismisses Bhargava’s plea against Jet-Etihad deal
*L&T wins housing contracts worth Rs 1,981 crore
*Lupin enters Mexico, buys Laboratorios Grin
*Dr Reddy’s launches Amlodipine Besylate and Atorvastatin Calcium Tablets
*RIL shuts Jamnagar paraxylene unit for maintenance
*Reliance MediaWorks delisting exit price fixed at Rs 61/share
*Nifty ends March series above 6600; SBI, Bharti big gainers
*India targeting spices exports of $2.3 billion in FY14
*Core CPI rigidity an important issue: Gokarn
*Delhi HC bars export of Natco’s Generic Cancer Drug.
